HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) CME Activity Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Even-Sapir, E. Search for Related Content PubMed PubMed Citation Articles by Even-Sapir, E.

Imaging of Malignant Bone Involvement by Morphologic, Scintigraphic, and Hybrid Modalities*

¹ Department of Nuclear Medicine, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

Detection of bone involvement is essential for optimal therapy of oncologic patients. The purpose of imaging is to identify early bone involvement, to determine the full extent of the skeletal disease, to assess the presence of accompanying complications—such as fractures and cord compression—and to monitor response to therapy. Detection of bone involvement by various imaging modalities is based on either direct visualization of tumor infiltration or detection of the reaction of bone to the malignant process. MRI can identify early involvement of bone marrow. CT, which depends mainly on bone destruction, provides detailed bone morphology. In nuclear medicine, uptake of ¹⁸F-FDG is directly into tumor cells, thus allowing for early detection and monitoring the response to therapy of tumor sites in the marrow, bone, and soft tissue, whereas increased uptake of ¹⁸F-fluoride and ^99mTc-methylene diphosphonate reflects the osteoblastic reaction of bone to the presence of tumor cells. The hybrid techniques SPECT/CT and PET/CT, recently introduced into clinical practice, provide a better anatomic localization of scintigraphic findings and may improve the diagnostic accuracy of SPECT and PET in detecting malignant bone involvement. The current review discusses the basis for the detection of malignant bone involvement by various morphologic and scintigraphic imaging modalities and the advantages and the limitations of each. Special emphasize is placed on the newer integrated technique of PET/CT. The role of imaging in identifying bone involvement in different malignant diseases is also discussed.

Related articles in JNM:

THIS MONTH IN JNM

JNM 2005 46: 8a-9a. [Full Text]  

This article has been cited by other articles:

				F. M. Paes, D. G. Kalkanis, P. A. Sideras, and A. N. Serafini FDG PET/CT of Extranodal Involvement in Non-Hodgkin Lymphoma and Hodgkin Disease RadioGraphics, January 1, 2010; 30(1): 269 - 291. [Abstract] [Full Text] [PDF]

				A. K. Buck, S. Nekolla, S. Ziegler, A. Beer, B. J. Krause, K. Herrmann, K. Scheidhauer, H.-J. Wester, E. J. Rummeny, M. Schwaiger, et al. SPECT/CT J. Nucl. Med., August 1, 2008; 49(8): 1305 - 1319. [Abstract] [Full Text] [PDF]

				B. Bybel, R. C. Brunken, F. P. DiFilippo, D. R. Neumann, G. Wu, and M. D. Cerqueira SPECT/CT Imaging: Clinical Utility of an Emerging Technology1 RadioGraphics, July 1, 2008; 28(4): 1097 - 1113. [Abstract] [Full Text] [PDF]

				D. S. Boss, R. V. Olmos, M. Sinaasappel, J. H. Beijnen, and J. H. M. Schellens Application of PET/CT in the Development of Novel Anticancer Drugs Oncologist, January 1, 2008; 13(1): 25 - 38. [Abstract] [Full Text] [PDF]

				R. L. Bridges, C. R. Wiley, J. C. Christian, and A. P. Strohm An Introduction to Na18F Bone Scintigraphy: Basic Principles, Advanced Imaging Concepts, and Case Examples J. Nucl. Med. Technol., June 1, 2007; 35(2): 64 - 76. [Abstract] [Full Text] [PDF]

				B. Fischer, J Mortensen, S. Langer, A Loft, A. Berthelsen, B. Petersen, G Daugaard, U Lassen, and H. Hansen A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis Ann. Onc., February 1, 2007; 18(2): 338 - 345. [Abstract] [Full Text] [PDF]

				E. Zamagni, C. Nanni, F. Patriarca, E. Englaro, P. Castellucci, O. Geatti, P. Tosi, P. Tacchetti, D. Cangini, G. Perrone, et al. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma Haematologica, January 1, 2007; 92(1): 50 - 55. [Abstract] [Full Text] [PDF]

				O. Israel and A. Kuten Early Detection of Cancer Recurrence: 18F-FDG PET/CT Can Make a Difference in Diagnosis and Patient Care J. Nucl. Med., January 1, 2007; 48(1_suppl): 28S - 35S. [Abstract] [Full Text] [PDF]

				W. Romer, A. Nomayr, M. Uder, W. Bautz, and T. Kuwert SPECT-Guided CT for Evaluating Foci of Increased Bone Metabolism Classified as Indeterminate on SPECT in Cancer Patients J. Nucl. Med., July 1, 2006; 47(7): 1102 - 1106. [Abstract] [Full Text] [PDF]

				L. Pace, M. Salvatore, and S. Del Vecchio Use of 99mTc-Sestamibi Scintigraphy in Multiple Myeloma. J. Nucl. Med., March 1, 2006; 47(3): 555a - 555a. [Full Text] [PDF]